Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Terminated3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04738292Phase 2Terminated
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
PrincipalinvestigatorStart date: 2021-10-05
NCT02720185Phase 2Terminated
Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Breast NeoplasmsTriple Negative Breast Neoplasms
PrincipalinvestigatorStart date: 2017-05-03
NCT01083641Phase 2Terminated
Estrogen for Triple Negative Breast Cancer
Female Breast Cancer
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sailaja Kamaraju, MD, MS

Medical College of Wisconsin

Moderately Similar
1 trials

Shared therapeutic areas:

ER-Positive Breast CancerHER2-negative Breast CancerMetastatic Cancer

Worked with same sponsors:

Context Therapeutics Inc.University of Wisconsin, Madison
Collaborated on 1 trial
Similarity Score34%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Breast NeoplasmsHER2-negative Breast CancerMetastatic Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Soo Chin Lee

National University Hospital, Singapore

Related
15 trials

Shared therapeutic areas:

Triple Negative Breast NeoplasmsHER2-negative Breast Cancer
Similarity Score10%

Kathy Miller, MD

Indiana University

Related
13 trials

Shared therapeutic areas:

Breast NeoplasmsTriple Negative Breast Neoplasms

Worked with same sponsors:

National Cancer Institute (NCI)University of Wisconsin, Madison
Similarity Score10%

Michal Lotem, MD

Hadassah Medical Organization

Related
3 trials

Shared therapeutic areas:

Metastatic CancerTriple Negative Breast Neoplasms
Similarity Score10%

Shimon Slavin, MD

Hadassah Medical Organization

Related
10 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score5%

Naiyer Rizvi, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Metastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Metastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Metastatic Cancer
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04738292Phase 2PrincipalInvestigator

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

ER-positive Breast CancerHER2-negative Breast CancerMetastatic Cancer
Terminated
NCT02720185Phase 2PrincipalInvestigator

Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR

Breast NeoplasmsTriple Negative Breast Neoplasms
Terminated
NCT01083641Phase 2PrincipalInvestigator

Estrogen for Triple Negative Breast Cancer

Female Breast Cancer
Terminated

All 3 trials loaded